Status:
COMPLETED
Sienna+MR Long-term Uptake
Lead Sponsor:
Kantonsspital Baden
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
Brief Summary
In a previous study in 2012/2013 patients were injected a superparamagnetic iron oxide for sentinel lymph node detection. In this follow up study we want to investigate how much of this tracer is stil...
Eligibility Criteria
Inclusion
- inclusion:
- participation in previous study
- informed consent
- no contraindications for MRI scan
- exclusion:
- contraindications for MRI scan
Exclusion
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03243435
Start Date
July 1 2016
End Date
April 1 2017
Last Update
August 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Baden
Baden, Canton of Aargau, Switzerland